The latest trading day saw Bristol Myers Squibb (BMY) settling at $56.29, representing a -0.16% change from its previous close.
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...
Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...
11hon MSN
The Centers for Medicare and Medicaid Services (CMS) released its second round of drug negotiation targets, a list of 15 ...
Jefferies has recently raised Bristol-Myers Squibb Co (BMY) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the ...
The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, announced the selection of 15 additional ...
Analysts at Leerink Partnrs boosted their Q4 2024 EPS estimates for Bristol-Myers Squibb in a report released on Sunday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback